AKT1 and neoplasm: Paul et al. [61] demonstrated that the binding between SDS22 (protein phosphatase 1 regulatory subunit) and AKT has the potential to lead to dephosphorylate ATK at Thr308 and Ser473 through PP1, and hence can inhibit proliferation, invasion, and migration of tumor cells.